The misuse and harms of gabapentin and pregabalin
Call for evidence description
The Advisory Council on the Misuse of Drugs (ACMD) is currently reviewing the evidence on the misuse and harms of pregabalin and gabapentin (gabapentinoids) in the United Kingdom.
This call for evidence will provide qualitative data to help the ACMD to:
-
inform the development of recommendations to government on how to best limit the harms posed by the potential misuse of gabapentinoids
-
assess whether the classification of gabapentin and pregabalin to Class C under the Misuse of Drugs Act 1971 has had the intended effect
The call is for any individual or organisation with knowledge or lived experience regarding the potential for harm caused by the misuse of pregabalin and gabapentin including:
- healthcare professionals
- researchers and academics
- service providers
Responses can be submitted on a personal basis or as a representative of an organisation.